Clinical Trial: A Study About Treatment Use in Adults With Narcolepsy Type 1 (NT1) in Europe and Canada

U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903220) titled 'A Study About Treatment Use in Adults With Narcolepsy Type 1 (NT1) in Europe and Canada' on Oct. 06.

Brief Summary: Narcolepsy is a sleep disorder that disrupts a person's regular sleep-wake cycle. It causes extreme sleepiness during the day (called excessive daytime sleepiness [EDS]), where a person may fall asleep without warning. Narcolepsy Type 1 (NT1) is a form of the condition in which people also have sudden, unexpected muscle weakness while staying conscious (called cataplexy). The usual care for NT1 focuses on managing symptoms and improving the sleep and wake cycle. It pays special attention to daytime sleepiness. Informat...